Shareholding disclosure

Bellevue Group AG

Declared position

4.97%

Threshold

Crossed upwards

Timeline

Published

13.12.2007

Transaction

—

Voting rights breakdown

Voting rights acquired4.97%

Voting rights sold4.97%

Below threshold0%

Notice details

CategoryGroup of shareholders

ExchangeXSWX

Notification ID

T5431D5191

Beneficial owner

Bellevue Group AG

Declared address

Bellevue Group AG, Küsnacht ZH

Short-Call-Optionen BB MEDTCH AG 720 408 4,97% Stillhalteroptionen im Zusammenhang mit der von BB MEDTECH AG ausgegebenen Pflichtwandelanleihe, Ausübungspreis CHF 3.10, Ausübungsfrist 6.3.2009, Realerfüllung. Für weitere Informationen: Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht/Zürich Adrian Brüngger oder Anja Stubenrauch, Tel. +41 44 267 67 00

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Bellevue Group AG

VT Finance AG13.12.2007T5431D5191

Disclosure summary

Bellevue Group AG disclosed a holding in VT Finance AG on the acquisition side, published by SIX Exchange Regulation on 13.12.2007, at 4.97% of voting rights. Notice category: Group of shareholders.

Disclosed position

4.97%

Voting rights acquired

Voting rights acquired4.97%

Voting rights sold4.97%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Bellevue Group AG disclosed a holding in VT Finance AG, published on 13.12.2007.

Publication date13.12.2007

Issuing companyVT Finance AG

Beneficial ownerBellevue Group AG

Declared addressBellevue Group AG, Küsnacht ZH

CategoryGroup of shareholders

Voting rights acquired4.97%

Voting rights sold4.97%

Below threshold0%

ExchangeXSWX

Notification IDT5431D5191

Commercial register

CHE-103.354.475

Registered

Zefix record

Conditions

Short-Call-Optionen BB MEDTCH AG 720 408 4,97% Stillhalteroptionen im Zusammenhang mit der von BB MEDTECH AG ausgegebenen Pflichtwandelanleihe, Ausübungspreis CHF 3.10, Ausübungsfrist 6.3.2009, Realerfüllung. Für weitere Informationen: Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht/Zürich Adrian Brüngger oder Anja Stubenrauch, Tel. +41 44 267 67 00

Source: SIX Exchange Regulation · Publication date: 13.12.2007

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open